Relevant bibliographies by topics / Diabetic Chronic Kidney Disease

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Diabetic Chronic Kidney Disease'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Diabetic Chronic Kidney Disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Diabetic Chronic Kidney Disease"

1

Yee, J. "Diabetic Kidney Disease: Chronic Kidney Disease and Diabetes." Diabetes Spectrum 21, no. 1 (2008): 8–10. http://dx.doi.org/10.2337/diaspect.21.1.8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shafi, Salman Tahir, Mohammad Saleem, Wajid Abdullah, Roshina Anjum, and Tahir Shafi. "CHRONIC KIDNEY DISEASE." Professional Medical Journal 23, no. 09 (2016): 1104–9. http://dx.doi.org/10.29309/tpmj/2016.23.09.1706.

Full text
Abstract:
Diabetes Mellitus and Hypertension are leading causes of chronic kidneydisease (CKD). There is limited data on frequency of retinopathy attributed to diabetes mellitusor hypertension in CKD patients in local population. Objective: to determine the frequency ofdiabetic and hypertensive retinopathy in patients with CKD not on hemodialysis or peritonealdialysis. Study Design: Cross Sectional. Setting: Nephorology ward at Sharif Medical CityHospital. Period: 6 Month. Methods: All patients between ages of 20-80 years with CKD notpreviously on renal replacement therapy (hemodialysis or peritoneal di
APA, Harvard, Vancouver, ISO, and other styles
3

Punit, Kumar1* Vipul Gupta2 Pranav Gupta3 Reena Tiwari4 Timur Beisenov1. "A Concise Review Study on Diabetic Nephropathy: Risk Factors, Pathogenesis, and Treatment." International Journal of Medical Science in Clinical Research and Review 7, no. 06 (2024): 1358–64. https://doi.org/10.5281/zenodo.14211102.

Full text
Abstract:
<strong><u>ABSTRACT</u></strong>: Diabetes-related kidney disease is known as diabetic nephropathy (DN). It is also known as renal disease and manifests progressively over many years. It is assumed that DN will require therapy for about one in five diabetics. In developed countries, diabetic kidney disease is assumed as mainly responsible for end-stage kidney disease. It is suggested that about 40% of cases of diabetes are prone to diabetic kidney diseases. Thus, the incidence of increasing cases of this disease is linked to diabetic patients. Proteinuria is also an important indicator of diab
APA, Harvard, Vancouver, ISO, and other styles
4

Williams, Mark E. "Diabetic Chronic Kidney Disease." Medical Clinics of North America 97, no. 1 (2013): xi—xii. http://dx.doi.org/10.1016/j.mcna.2012.11.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rini, Sulistio, Suharyo Hadisaputro, Lestariningsih Lestariningsih, Heri Nugroho, and Selamat Budijitno. "Faktor Risiko Penyakit Ginjal Kronik Diabetes (PGK-DM) pada Diabetes Mellitus Tipe-2 (Studi di RSUD DR Soedarso Kota Pontianak Provinsi Kalimantan Barat)." Jurnal Epidemiologi Kesehatan Komunitas 3, no. 1 (2018): 101. http://dx.doi.org/10.14710/j.e.k.k.v3i1.4028.

Full text
Abstract:
Background: Prevalence of type-2 diabetes mellitus have increased significantly. The increasing number of people with diabetes has a major impact on the development of chronic diabetic kidney disease. The research was aimed to clarify several risk factors of chronic diabetic kidney disease on type-2 diabetes mellitus (CDK-DM).Method: The research was based on case control study design. The number of respondents was 140 respondents consisting 70 cases and 70 controls that met the criteria of inclusion and exclusion. The cases were patients with type-2 chronic diabetic kidney disease stadium 2-5.
APA, Harvard, Vancouver, ISO, and other styles
6

Rini, Sulistio, Suharyo Hadisaputro, Lestariningsih Lestariningsih, Heri Nugroho, and Selamat Budijitno. "Faktor Risiko Penyakit Ginjal Kronik Diabetes (PGK-DM) pada Diabetes Mellitus Tipe-2 (Studi di RSUD DR Soedarso Kota Pontianak Provinsi Kalimantan Barat)." Jurnal Epidemiologi Kesehatan Komunitas 3, no. 2 (2018): 101. http://dx.doi.org/10.14710/j.e.k.k.v3i2.4029.

Full text
Abstract:
Background: Prevalence of type-2 diabetes mellitus have increased significantly. The increasing number of people with diabetes has a major impact on the development of chronic diabetic kidney disease. The research was aimed to clarify several risk factors of chronic diabetic kidney disease on type-2 diabetes mellitus (CDK-DM).Method: The research was based on case control study design. The number of respondents was 140 respondents consisting 70 cases and 70 controls that met the criteria of inclusion and exclusion. The cases were patients with type-2 chronic diabetic kidney disease stadium 2-5.
APA, Harvard, Vancouver, ISO, and other styles
7

Rini, Sulistio, Suharyo Hadisaputro, Lestariningsih Lestariningsih, Heri Nugroho, and Selamat Budijitno. "Faktor Risiko Penyakit Ginjal Kronik Diabetes (PGK-DM) pada Diabetes Mellitus Tipe-2 (Studi di RSUD DR Soedarso Kota Pontianak Provinsi Kalimantan Barat)." Jurnal Epidemiologi Kesehatan Komunitas 3, no. 1 (2018): 101. http://dx.doi.org/10.14710/jekk.v3i1.4028.

Full text
Abstract:
Background: Prevalence of type-2 diabetes mellitus have increased significantly. The increasing number of people with diabetes has a major impact on the development of chronic diabetic kidney disease. The research was aimed to clarify several risk factors of chronic diabetic kidney disease on type-2 diabetes mellitus (CDK-DM).Method: The research was based on case control study design. The number of respondents was 140 respondents consisting 70 cases and 70 controls that met the criteria of inclusion and exclusion. The cases were patients with type-2 chronic diabetic kidney disease stadium 2-5.
APA, Harvard, Vancouver, ISO, and other styles
8

Rini, Sulistio, Suharyo Hadisaputro, Lestariningsih Lestariningsih, Heri Nugroho, and Selamat Budijitno. "Faktor Risiko Penyakit Ginjal Kronik Diabetes (PGK-DM) pada Diabetes Mellitus Tipe-2 (Studi di RSUD DR Soedarso Kota Pontianak Provinsi Kalimantan Barat)." Jurnal Epidemiologi Kesehatan Komunitas 3, no. 2 (2018): 101. http://dx.doi.org/10.14710/jekk.v3i2.4029.

Full text
Abstract:
Background: Prevalence of type-2 diabetes mellitus have increased significantly. The increasing number of people with diabetes has a major impact on the development of chronic diabetic kidney disease. The research was aimed to clarify several risk factors of chronic diabetic kidney disease on type-2 diabetes mellitus (CDK-DM).Method: The research was based on case control study design. The number of respondents was 140 respondents consisting 70 cases and 70 controls that met the criteria of inclusion and exclusion. The cases were patients with type-2 chronic diabetic kidney disease stadium 2-5.
APA, Harvard, Vancouver, ISO, and other styles
9

R Shinde, Shruti, Avinash Chaudhari, and Amar Kulkarni. "Study of Thyroid Profile in Diabetic Versus Non - Diabetic Chronic Kidney Disease Patients." International Journal of Science and Research (IJSR) 13, no. 8 (2024): 1517–22. http://dx.doi.org/10.21275/sr24825130803.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Klimontov, V. V., and A. I. Korbut. "Normoalbuminuric chronic kidney disease in diabetes." Terapevticheskii arkhiv 90, no. 10 (2018): 94–98. http://dx.doi.org/10.26442/terarkh201890104-98.

Full text
Abstract:
Urinary albumin excretion (UAE) is widely used in clinical practice as indicator of diabetic kidney disease. According to the classical concept of the natural course of diabetic nephropathy, an increase in UAE usually precedes a decline in renal function. Meanwhile, a growing body of evidences indicates a high prevalence of normoalbuminuric chronic kidney disease (NA-CKD) in diabetic subjects, especially among patients with type 2 diabetes. An increase in NA-CKD prevalence can be results of improved glucose, blood pressure, and lipid control, widespread use of renin-angiotensin system blockers
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Diabetic Chronic Kidney Disease"

1

Wong, May Yue Wai. "Novel anti-fibrotic agents in acute and chronic kidney disease." Thesis, The University of Sydney, 2020. https://hdl.handle.net/2123/22015.

Full text
Abstract:
The thesis spans the spectrum of causative and therapeutic aspects of chronic kidney disease (CKD), which is a significant and growing health burden. While it is desirable that these findings will translate into effective strategies to prevent CKD, kidney impairment is frequently diagnosed when advanced renal fibrosis has already developed. Thus, the second part of this thesis focuses on therapy and explores whether anti-inflammatory or anti fibrotic agents such as semicarbazide sensitive amine oxidase (SSAO) inhibitor or cationic-independent mannose 6-phosphate receptor (CI-6MPR) inhibitors s
APA, Harvard, Vancouver, ISO, and other styles
2

Palanca, Ana. "Subclinical atherosclerosis in chronic kidney disease and diabetes." Doctoral thesis, Universitat Autònoma de Barcelona, 2020. http://hdl.handle.net/10803/670707.

Full text
Abstract:
La malaltia cardiovascular és la primera causa de morbiditat i mortalitat mundial. Els individus amb diabetis i malaltia renal crònica (MRC) presenten un major risc d’esdeveniments cardiovasculars (ECV) respecte a la població general. En la diabetis, l’increment de el risc cardiovascular és heterogeni i s’ha relacionat amb el grau d’afectació renal. D’altra banda, els algoritmes tradicionals per calcular el risc cardiovascular no traslladen amb suficient precisió el risc futur de ECV. L’avaluació de l’aterosclerosi subclínica (AS) mitjançant ecografia multiterritorial representa una eina vàlid
APA, Harvard, Vancouver, ISO, and other styles
3

Shaman, Ahmed M. "Improving outcomes for patients with chronic kidney disease." Thesis, The University of Sydney, 2020. https://hdl.handle.net/2123/22328.

Full text
Abstract:
There is clear evidence in the literature that the global burden of chronic kidney disease (CKD) is increasing. CKD patients are at high risk of cardiovascular morbidity and mortality which appeared to proportionally increase as kidney function deteriorates toward end-stage kidney disease (ESKD) requiring dialysis. Given the increasing prevalence, worsened outcomes associated with CKD as well as the financial cost associated with its management, there is a clear need for evidence-based interventions to lower the risk and improve outcomes in this high-risk population. This thesis aimed at
APA, Harvard, Vancouver, ISO, and other styles
4

Sukkar, Louisa. "Improving outcomes in chronic kidney disease and its associated comorbidities." Thesis, The University of Sydney, 2021. https://hdl.handle.net/2123/25667.

Full text
Abstract:
Background: Chronic kidney disease (CKD) and its associated comorbidities such as diabetes and cardiovascular disease (CVD) are major drivers of death and disability around the world. Methods: This thesis by publication aims to examine the burden of CKD and diabetes in the community and explores the ways in which this burden can be ameliorated. These aims are achieved by various methodologies. A novel comprehensive population-based data linkage study is used to estimate CKD and diabetes incidence and associations as well as assesses health service delivery of proven cardioprotective treatments
APA, Harvard, Vancouver, ISO, and other styles
5

Walter, Debra L. "Renal Consequences of Coxsackievirus Infection and Type 1 Diabetes in Non-obese Diabetic Mice." Ohio University / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=ohiou1526020616767063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Herrera-Añazco, Percy, Alvaro Taype-Rondan, María Lazo-Porras, Quintanilla E. Alberto, Victor Manuel Ortiz-Soriano, and Adrian V. Hernandez. "Prevalence of chronic kidney disease in Peruvian primary care setting." BMJ Publishing Group Ltd, 2017. http://hdl.handle.net/10757/622208.

Full text
Abstract:
Background: Chronic Kidney Disease (CKD) is a worldwide public health problem. There are few studies in Latin America, especially in primary care settings. Our objective was to determine the prevalence, stages, and associated factors of CKD in primary care setting. Methods: We did a retrospective secondary analysis of a database from the Diabetes and Hypertension Primary Care Center of the Peruvian Social Security System (EsSalud) in Lima, Peru. We defined CKD as the presence of eGFR <60 mL/min and/or albuminuria >30 mg/day in 24 h, according to Kidney Disease: Improving Global Outcomes
APA, Harvard, Vancouver, ISO, and other styles
7

Glastras, Sarah Jean. "Maternal obesity predisposes offspring towards the development of chronic kidney disease." Thesis, The University of Sydney, 2016. http://hdl.handle.net/2123/15709.

Full text
Abstract:
Obesity together with insulin resistance promotes multiple metabolic abnormalities and is strongly associated with increased risk of chronic disease including type 2 diabetes (T2D), cardiovascular disease (CVD) and chronic kidney disease (CKD). The incidence of obesity is rising and affects all different stages of the lifespan. Importantly, obesity in women of reproductive has potential ramifications for offspring health. Maternal obesity is known to influence offspring development of obesity, T2D and CVD. In contrast, the relationship between maternal obesity and CKD has been less clearly def
APA, Harvard, Vancouver, ISO, and other styles
8

Mcdonald, H. I. "The epidemiology of infections among older people with diabetes mellitus and chronic kidney disease." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2015. http://researchonline.lshtm.ac.uk/2528130/.

Full text
Abstract:
This thesis describes the epidemiology of community-acquired infections among older people with diabetes without a history of renal replacement therapy, according to markers of chronic kidney disease (CKD): proteinuria and reduced estimated glomerular filtration rate (eGFR). The thesis uses linked electronic health records from primary and secondary care, and mortality records. Among a cohort of 219,145 patients with diabetes aged ≥65 years there was a high burden of community-acquired infection: lower respiratory tract infections (LRTIs) having the highest crude rate (152.7/1,000 years) follo
APA, Harvard, Vancouver, ISO, and other styles
9

Vergara, Arana Ander. "Mecanismos de acción del bloqueo SGLT2 en la protección cardiorrenal en la diabetes tipo 2." Doctoral thesis, Universitat Autònoma de Barcelona, 2021. http://hdl.handle.net/10803/674051.

Full text
Abstract:
La malaltia renal diabètica (MRD) és la principal causa d’inici de diàlisi en el món i s’acompanya d’una elevada morbimortalitat. Fins al 2016 només dos grups farmacològics que bloquegen el sistema renina-angiotensina (SRA): els inhibidors de l’enzim convertidor d’angiotensina (IECAs) i els antagonistes el receptor d’angiotensina II (ARA2), van demostrar frenar la progressió de la MRD. Recentment, dos grups farmacològics: els inhibidors del cotransportador de sodi-glucosa tipus 2 (iSGLT2) i els antagonistes selectius del receptor d’endotelina (ARE) han demostrat efectes protectors enfront de l
APA, Harvard, Vancouver, ISO, and other styles
10

Pereira, Filipa Alexandra Antunes Vences de Matos. "Patient associations: raising awareness on chronic diseases." Master's thesis, Universidade de Aveiro, 2015. http://hdl.handle.net/10773/16582.

Full text
Abstract:
Mestrado em Biomedicina Farmacêutica<br>The patient associations assume a significant role in representing the patients’ rights, sharing information on the diseases, accessing the available resources, maintaining important interactions with other relevant stakeholders and facing challenges. These organizations provide an important support not only to the patients, but also to their families and friends, who are most of the times their direct caregivers. Currently, the patient empowerment has been highly discussed. This project aims to demonstrate in five different clinical disorders what ar
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Diabetic Chronic Kidney Disease"

1

Tong, Bin. Comorbidity of cardiovascular disease, diabetes, and chronic kidney disease in Australia. Australian Institute of Health and Welfare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tong, Bin. Comorbidity of cardiovascular disease, diabetes, and chronic kidney disease in Australia. Australian Institute of Health and Welfare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wada, Takashi, Kengo Furuichi, and Naoki Kashihara, eds. Diabetic Kidney Disease. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-9301-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Yang, Junwei, and Weichun He, eds. Chronic Kidney Disease. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-32-9131-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

S, Cappell Mitchell, ed. Chronic kidney disease. Saunders, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kumar, Singh Ajay, ed. Chronic kidney disease. Saunders, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Piracha, Kashif. Chronic Kidney Disease Complications. Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-49922-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

McCauley, Jerry, Seyed Mehrdad Hamrahian, and Omar H. Maarouf, eds. Approaches to Chronic Kidney Disease. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-83082-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Haddad, Maha N., Erica Winnicki, and Stephanie Nguyen, eds. Adolescents with Chronic Kidney Disease. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-97220-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Weir, Matthew R., and Edgar V. Lerma, eds. Chronic Kidney Disease and Hypertension. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-1982-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Diabetic Chronic Kidney Disease"

1

Cai, Ting, and Junwei Yang. "Diabetic Kidney Disease." In Chronic Kidney Disease. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-32-9131-7_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Maarouf, Omar H. "Diabetic Kidney Disease." In Approaches to Chronic Kidney Disease. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-83082-3_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

MacIsaac, Richard J., George Jerums, and Gerald F. Watts. "Diabetic Chronic Kidney Disease." In Diabetes. Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118405550.ch2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rosas, Sylvia E., and Samer Nasser. "Diabetic Kidney Disease: Increasing Hope with Transformative Therapies." In Management of Chronic Kidney Disease. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-42045-0_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chaudhary, Kunal, J. P. Buddineni, Joshua Botdorf, and Adam Whaley-Connell. "Hypertension in Chronic Kidney Disease." In Diabetes and Hypertension. Humana Press, 2012. http://dx.doi.org/10.1007/978-1-60327-357-2_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kara, Meryem Tuncel, Moshe Levi, and Devasmita Choudhury. "Diabetes and Chronic Kidney Disease." In Management of Chronic Kidney Disease. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-54637-2_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Icks, Andrea, and Michael Koch. "Epidemiology of Chronic Kidney Disease in Diabetes." In Diabetes and Kidney Disease. Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118494073.ch2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Krikorian, Armand, and Joumana T. Chaiban. "Dyslipidemia in Diabetes Mellitus and Chronic Kidney Disease." In Diabetes and Kidney Disease. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0793-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Taal, Maarten W., and Barry M. Brenner. "How to Achieve Maximal Renoprotection in Non-Diabetic Chronic Renal Disease." In Improving Prognosis for Kidney Disorders. Springer Netherlands, 2002. http://dx.doi.org/10.1007/978-94-017-1848-6_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Elger, Meaghan, Arti Sharma Parpia, and Dana Whitham. "Diabetes Mellitus and Chronic Kidney Disease (Stages 1–5)." In Nutrition in Kidney Disease. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-44858-5_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Diabetic Chronic Kidney Disease"

1

V, Sivakumar, Dharshini S, Dhanush Kumar M, Shanmugaganesh M, and Vijayalakshmi K. "Early Detection of Chronic Kidney Disease in Diabetic Patients using Explainable AI." In 2025 5th International Conference on Pervasive Computing and Social Networking (ICPCSN). IEEE, 2025. https://doi.org/10.1109/icpcsn65854.2025.11035905.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sridevi, Parama, Padmapriya Velupillai Meikandan, Paramita Basak Upama, et al. "ML-Based Chronic Kidney Disease and Diabetes Prediction with Feature Effect Analysis Using SHAP." In 2024 IEEE 48th Annual Computers, Software, and Applications Conference (COMPSAC). IEEE, 2024. http://dx.doi.org/10.1109/compsac61105.2024.00117.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Guazzo, Alessandro, Enrico Longato, Gian Paolo Fadini, Giovanni Sparacino, Rema Padman, and Barbara Di Camillo. "Characterization of Chronic Kidney Disease Progression in Patients with Diabetes via Group-Based Multi-Trajectory Modeling." In 2024 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2024. https://doi.org/10.1109/embc53108.2024.10781792.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Allam, Zyad, Reem Jamal, Fathan Shajrah, and Sawsan Hilal. "Chronic Kidney Disease Detection: A Comparative study." In 2023 4th International Conference on Data Analytics for Business and Industry (ICDABI). IEEE, 2023. http://dx.doi.org/10.1109/icdabi60145.2023.10629400.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ravi Kumar, R., Srinivas Mudepalli, V. Sujay, Jayapal Lande, and Sallauddin Mohmmad. "An Empirical Method For Chronic Kidney Disease Prediction." In 2024 15th International Conference on Computing Communication and Networking Technologies (ICCCNT). IEEE, 2024. http://dx.doi.org/10.1109/icccnt61001.2024.10724236.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rani, Ritu, Kanwarpartap Singh Gill, Deepak Upadhyay, and Swati Devliyal. "XGBoost-Driven Insights: Enhancing Chronic Kidney Disease Detection." In 2024 5th International Conference on Smart Electronics and Communication (ICOSEC). IEEE, 2024. http://dx.doi.org/10.1109/icosec61587.2024.10722440.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kumar, Ashish, Aadrika Singh, Aditya Saxena, Aniket Thakur, and Ayush Kumar Bhartiya. "Enhanced Predictive Modeling for Chronic Kidney Disease Diagnosis." In 2024 1st International Conference on Advanced Computing and Emerging Technologies (ACET). IEEE, 2024. http://dx.doi.org/10.1109/acet61898.2024.10730144.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

P, Patil Dilip, Indranil Jayant Kulkarni, and Rohan S. Phatak. "Cardiac Function Evaluation in Chronic Kidney Disease Patients." In 2024 International Conference on Healthcare Innovations, Software and Engineering Technologies (HISET). IEEE, 2024. http://dx.doi.org/10.1109/hiset61796.2024.00020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Santhiya, K., D. Murugan, and K. Navaz. "Chronic Kidney Disease Prediction Using Machine Learning Algorithms." In 2024 International Conference on Integration of Emerging Technologies for the Digital World (ICIETDW). IEEE, 2024. https://doi.org/10.1109/icietdw61607.2024.10939413.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Thaney, Rohan, Shivani Shivani, Jothikumar C, and V. Nallarasan. "Chronic Kidney Disease Detection using Deep Learning Models." In 2024 International Conference on Distributed Systems, Computer Networks and Cybersecurity (ICDSCNC). IEEE, 2024. https://doi.org/10.1109/icdscnc62492.2024.10939493.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Diabetic Chronic Kidney Disease"

1

Murphy-Ullrich, Joanne E. The Endoplasmic Reticulum Stress Protein Calreticulin in Diabetic Chronic Kidney Disease. Defense Technical Information Center, 2015. http://dx.doi.org/10.21236/ada624022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zhang, Mingzhu, Wujisiguleng Bao, Luying Sun, Zhi Yao, and Xiyao Li. Efficacy and safety of finerenone in chronic kidney disease associated with type 2 diabetes: meta-analysis of randomized clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.3.0020.

Full text
Abstract:
Review question / Objective: To assess the beneficial effect and safety of finerenone for patients with chronic kidney disease associated with type 2 diabetes. Condition being studied: Chronic kidney disease (CKD) is a major contributor to morbidity and mortality from non-communicable diseases, affecting almost 700 million people worldwide. Approximately 40% of patients with diabetes have CKD, which exposes them to a 3-fold higher risk of cardiovascular death versus those with T2D alone. Strategies to protect the kidneys of patients with CKD and T2D may reduce their risk of cardiovascular even
APA, Harvard, Vancouver, ISO, and other styles
3

Husidic, Dejvid. The Effect of SGLT-2 Inhibitors in Non-Diabetic Patients with Diseases Such as Congestive Heart Failure and Chronic Kidney Disease. Iowa State University, 2022. http://dx.doi.org/10.31274/cc-20240624-1425.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Yu, Winifred W., Elise Digga, Courtney Luterbach, et al. Linking Dental Services to Treatment Outcomes for Chronic Kidney Disease: A Rapid Response Review. Agency for Healthcare Research and Quality, 2024. https://doi.org/10.23970/ahrqepcrapid_dental_kidney.

Full text
Abstract:
Summary: Notwithstanding the gaps noted above or the heterogeneity in the studies, the patient population or periodontitis severity, there is consistent evidence showing a reduction in inflammation post-periodontal treatment in patients with CKD. The evidence for mortality and cardiovascular outcomes also offers evidence (although weak) that these outcomes may be favorable to patients with CKD in the medium term. The Centers for Disease Control recommends oral health maintenance for patients with diabetes. CKD is common in people with type 1 and type 2 diabetes. Approximately 1 in 2 adults wit
APA, Harvard, Vancouver, ISO, and other styles
5

Horvit, Andrew, and Donald Molony. A Systematic Review and Meta-Analysis of Mortality and Kidney Function in Uranium – Exposed Individuals. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.4.0122.

Full text
Abstract:
Review question / Objective: 1) In humans, how does environmental and/or occupational exposure to uranium affect the risk of mortality due to primary kidney disease compared to unexposed individuals? (2) In humans, how does environmental and/or occupational exposure to uranium affect the risk of developing kidney failure compared to unexposed individuals? Eligibility criteria: We included cohort studies that evaluate the risk of CKD/ESKD due to uranium exposure. We also included cohort studies that evaluate standardized mortality due to all-cause mortality, kidney cancer, chronic kidney diseas
APA, Harvard, Vancouver, ISO, and other styles
6

Gupta, Shikhar, Mehtab Ahmed, Sayema ., Azam Haseen, and Saif Quaiser. Relevance of Preoperative Vessel Mapping and Early Postoperative Ultrasonography in Predicting AV Fistula Failure in Chronic Kidney Disease Patients. Science Repository, 2024. http://dx.doi.org/10.31487/j.rdi.2023.02.02.

Full text
Abstract:
Introduction: The increasing prevalence of chronic kidney disease (CKD), coupled with advancements in the diagnosis and treatment of renal diseases and improvements in life expectancy, has led to a greater number of patients requiring hemodialysis. The preferred method of vascular access for hemodialysis is AV fistula formation; however, it is associated with a high rate of failure. In our prospective study, we focused on 40 CKD patients planned for initiation of maintenance hemodialysis. Methods: We employed preoperative ultrasound mapping to assess cephalic vein diameter, compressibility, an
APA, Harvard, Vancouver, ISO, and other styles
7

Choi, Chiwon, Myeong Gyu Kim, and Jae Hyun Kim. Effect of Xanthine Oxidase Inhibitors on Renal Function in Chronic Kidney Disease Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.5.0024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zhu, Huafeng, Haixing Fang, Qunfeng Xia, Jianfeng Cai, and Tianwei Fu. Finerenone reduces risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.3.0052.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Shah, Vallabh, Yiliang Zhu, Jessica Reno, Kevin English, Vernon Pankratz, and Mark Unruh. Effect of COVID-19 Pandemic on Healthcare Access, Anxiety, and Health-Related Behaviors among American Indian People with or at Risk for Diabetes or Chronic Kidney Disease. Patient-Centered Outcomes Research Institute (PCORI), 2024. http://dx.doi.org/10.25302/01.2024.ad.151133553_c19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nelson, Julie. Feline chronic kidney disease: Pathophysiology and diagnosis. Iowa State University, 2021. http://dx.doi.org/10.31274/cc-20240624-721.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Diabetic Chronic Kidney Disease' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography